Corvus Pharmaceuticals Inc buy Cantor Fitzgerald
Start price
01.04.24
/
50%
€1.67
Target price
01.04.25
-
Performance (%)
71.74%
End price
02.04.25
€2.88
Summary
This prediction ended on 02.04.25 with a price of €2.88. With a performance of 71.74% the BUY prediction by Cantor_Fitzgerald was a big success. Cantor_Fitzgerald has a follow-up prediction for Corvus Pharmaceuticals Inc where he still thinks Corvus Pharmaceuticals Inc is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | 141.894% | 141.894% | 176.379% |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for CRVS provided by MarketBeat
In the thread Trading Corvus Pharmaceuticals Inc
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€7.16
11.12.25
11.12.25
-
11.12.26
11.12.26
164.80%
20.01.26
20.01.26
Stopped prediction by Cantor_Fitzgerald for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€1.51
07.09.23
07.09.23
€3.74
07.09.24
07.09.24
146.36%
08.09.24
08.09.24